Terms: = Germ cell tumor AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181 AND Treatment
11 results:
1. The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Feichtenschlager V; Chen L; Zheng YJ; Ho W; Sanlorenzo M; Vujic I; Fewings E; Lee A; Chen C; Callanan C; Lin K; Qu T; Hohlova D; Vujic M; Hwang Y; Lai K; Chen S; Nguyen T; Muñoz DP; Kohwi Y; Posch C; Daud A; Rappersberger K; Kohwi-Shigematsu T; Coppé JP; Ortiz-Urda S
Mol Cancer; 2024 Feb; 23(1):40. PubMed ID: 38383439
[TBL] [Abstract] [Full Text] [Related]
2. METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma.
Vaid R; Thombare K; Mendez A; Burgos-Panadero R; Djos A; Jachimowicz D; Lundberg KI; Bartenhagen C; Kumar N; Tümmler C; Sihlbom C; Fransson S; Johnsen JI; Kogner P; Martinsson T; Fischer M; Mondal T
Nucleic Acids Res; 2024 Mar; 52(5):2648-2671. PubMed ID: 38180812
[TBL] [Abstract] [Full Text] [Related]
3. Cholesterol homeostasis confers glioma malignancy triggered by hnrnpa2b1-dependent regulation of SREBP2 and LDLR.
Zhang J; Liu B; Xu C; Ji C; Yin A; Liu Y; Yao Y; Li B; Chen T; Shen L; Wu Y
Neuro Oncol; 2024 Apr; 26(4):684-700. PubMed ID: 38070488
[TBL] [Abstract] [Full Text] [Related]
4. Roles of the m
Yuan F; Cai X; Cong Z; Wang Y; Geng Y; Aili Y; Du C; Zhu J; Yang J; Tang C; Zhang A; Zhao S; Ma C
Front Immunol; 2022; 13():798583. PubMed ID: 35558067
[TBL] [Abstract] [Full Text] [Related]
5. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
6. Cancer Neoepitopes for Immunotherapy: Discordance Between tumor-Infiltrating T cell Reactivity and tumor MHC Peptidome Display.
Wickström SL; Lövgren T; Volkmar M; Reinhold B; Duke-Cohan JS; Hartmann L; Rebmann J; Mueller A; Melief J; Maas R; Ligtenberg M; Hansson J; Offringa R; Seliger B; Poschke I; Reinherz EL; Kiessling R
Front Immunol; 2019; 10():2766. PubMed ID: 31921104
[TBL] [Abstract] [Full Text] [Related]
7. [Expression of heterogeneous nuclear ribonucleo-protein A2B1 in mouse cerebellar development and human medulloblastoma].
Zhao SL; Zhao F; Li Q; Zhang J; Zhang ZW; Li CD; Liu PN; Tong WM; Niu YM
Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):694-699. PubMed ID: 31495089
[No Abstract] [Full Text] [Related]
8. Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN).
Kong G; Grozinsky-Glasberg S; Hofman MS; Akhurst T; Meirovitz A; Maimon O; Krausz Y; Godefroy J; Michael M; Gross DJ; Hicks RJ
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):718-727. PubMed ID: 30343432
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.
Behera R; Kaur A; Webster MR; Kim S; Ndoye A; Kugel CH; Alicea GM; Wang J; Ghosh K; Cheng P; Lisanti S; Marchbank K; Dang V; Levesque M; Dummer R; Xu X; Herlyn M; Aplin AE; Roesch A; Caino C; Altieri DC; Weeraratna AT
Clin Cancer Res; 2017 Jun; 23(12):3181-3190. PubMed ID: 28232477
[No Abstract] [Full Text] [Related]
10. Carcinoid tumors of the rectum: a multi-institutional international collaboration.
Shields CJ; Tiret E; Winter DC;
Ann Surg; 2010 Nov; 252(5):750-5. PubMed ID: 21037430
[TBL] [Abstract] [Full Text] [Related]
11. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract] [Full Text] [Related]
